INmune Bio Announces $4.5 Million Registered Direct Offering and Private Placement
INmune Bio (NASDAQ: INMB) has entered into an agreement to raise approximately $4.5 million in gross proceeds through a registered direct offering and a private placement. The deal involves the sale of 3 million common shares to an institutional investor. In addition to the share sale, the company will issue warrants that allow for up to 3 million additional shares to be issued. This capital raise is intended to provide liquidity for the biotechnology firm as it continues its clinical operations.
Tickers: $INMB
Topics: capital raising stock offering warrants